Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price6.31 USD
Fair value8.05Our model only; only one analyst covers it, too few to cross-check it.
Ethical score89.7/100
Value readUndervaluedas of 3 Nov 2026
Our investment reviews on this name
2026-10-20Read Accumulation6.62-4.7% to today Markdown gives way to Accumulation
2026-10-11Read Markdown6.58-4.1% to today ✓Accumulation gives way to Markdown after a 26% rise in 10 weeks
2026-08-03Read Accumulation5.23+20.7% to today ✓Markup gives way to Accumulation
2026-07-02Read Markup5.36+17.7% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Kolibri Global Energy Inc. holds its Accumulation at $6.31. Consolidating, no directional conviction, held for 1095 days.
As held on the ledger · 2026-11-03
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 1095 days
Price at the screen
$6.31
Valuation
13.04 trailing · 8.38 forward price to earnings
Values screen
PASS· score 89.7
Beta
1.48
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
25.58%
Below 33%
Interest-bearing debt is just 25.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
1.69%
Below 33%
Cash held in interest-bearing accounts and securities is 1.7% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
0.04%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Kolibri Global Energy clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 26%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when KGEI's ethical verdict changes
Today KGEI passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our model only; only one analyst covers it, too few to cross-check it.
Our analysis reads Undervalued vs our fair value, as of 3 Nov 2026: it trades at roughly a 22% discount to our $8.05 fair value, weak competitive moat, 102.90% revenue growth.
Fair value range in USD, drawn from the 2026-11-03 screen. The gold marker is the market price at the same screen. A 21.6% discount to the base estimate.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Where our models see it going: fair-value estimate $8.05, with a range of $8.05 to $9.00, dated to the 2026-11-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Small Shale Operator At A Cyclical Discount
Every barrel lifted from the Caney Shale must still clear volatile prices and bigger rivals. Kolibri Global Energy sits in that patch with revenue up 20 percent and a forward earnings multiple of 8.2 times. The shares trade at a 28 percent discount to our fair value, which is the sort of gap that appears when the market prices in the next downturn before it arrives.
The business throws off a 23 percent profit margin and clears our ethical screen without issue. One analyst sees an $8 target, well above the current price, and the balance sheet looks light enough to keep the drills turning through a soft patch.
Yet this is exactly the cyclical value trap to watch. Low multiples often sit on peak earnings in oil and gas, a weak moat leaves it exposed to bigger players, and 7 percent return on equity shows limited pricing power once prices turn. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
KGEI trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-01Accumulation$7.18+8.5%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 38% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it strong buy, with a mean price target of $9.
2026-10-20Accumulation · changed$6.62+0.6%Entry 8
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 35% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it strong buy, with a mean price target of $9.
2026-10-11Markdown · changed$6.58+0.0%Entry 7
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it none, with a mean price target of $9.
2026-10-02Accumulation$6.58+8.9%Entry 6
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it none, with a mean price target of $9.
2026-09-03Accumulation$6.04+15.5%Entry 5
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 15.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it none, with a mean price target of $8.
2026-08-03Accumulation · changed$5.23-2.4%Entry 4
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.4% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it strong buy, with a mean price target of $8.
2026-07-18Markup$5.36+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it strong buy, with a mean price target of $8.
2026-07-03Markup$5.36+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Markup$5.36Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.